New medical device improves blood pressure control

	Tweet

Physicians at the Hypertension and Vascular Disease Center at Wake Forest University Baptist Medical Center have proven that a new medical device improves blood pressure management in patients with the most common form of uncontrolled hypertension.

In their study, the Consideration of Noninvasive Hemodynamic Monitoring to Target Reduction of Blood Pressure Levels (CONTROL), hypertension researchers hypothesized that hypertension therapy guided by a new noninvasive device called impedance cardiography (ICG) could aid primary care physicians in reducing blood pressure more effectively. ICG devices measure hemodynamics, the study of how rapidly blood circulates through the body (cardiac output) and the force the heart pumps against (systemic vascular resistance).

“Hypertension is a hemodynamic-related disorder,” said Carlos M. Ferrario, M.D., director of the Hypertension and Vascular Disease Center at Wake Forest Baptist, and lead researcher of the CONTROL study recently published in Hypertension, a Journal of the American Heart Association. “Blood pressure rises as a result of increased systemic vascular resistance, cardiac output, fluid volume or a combination of these factors.”

Historically, physicians could not assess either cardiac output or systemic vascular resistance without invasive or expensive methods. The ICG test (brand name BioZ? manufactured by CardioDynamics Inc., a funding source of the study) measures both of these parameters noninvasively and inexpensively.

In the CONTROL trial, Ferrario’s team discovered that ICG-guided treatments improved blood pressure control rates in resistant hypertension commonly treated by primary care physicians.

“Our study shows that we can do much better clinically in tailoring anti-hypertensive therapy based on actual determination of the hemodynamic cause, in the office of a primary care practitioner,” said Ferrario.

Impedance cardiography-aided patients in the study experienced a significant reduction in blood pressure. They were 35 percent more likely to achieve a blood pressure goal of <140/90mm Hg and 103 percent more likely to achieve the more aggressive goal of 130/85mm Hg.

Hypertension is a common disease shared by approximately 65 million Americans and 1 billion people around the world. Of this population, it is estimated that only one-third of patients diagnosed with hypertension have controlled blood pressure (<140/90mm Hg). A major public health concern, it’s the most common reason adults visit physicians in the United States and a significant risk factor for stroke, heart attack, renal disease and heart failure.

http://www1.wfubmc.edu

RELATED STORIES:
Simple procedure lowers blood pressure in kidney disease patients   WHO warns of high blood pressure, diabetes, obesity   Causes of hypertension start early, doctor warns   Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent   Changes in Gene Expression May Help Explain High Blood Pressure in Pregnancy   Swapping protein for sugar may help blood pressure   Drinking black tea may cut blood pressure   Middle-aged men with upper-normal blood pressure at risk for AF   Pollution tied to disease risk in L.A. black women   Birth Defects May be Linked to High Blood Pressure, Not Use of ACE Inhibitors   Poor sleep quality increases risk of high blood pressure   Pilot study suggests new approach to treat preeclampsia

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]